Drug Profile
Research programme: vaccines - OPKO Health/Academia Sinica
Latest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Academia Sinica; OPKO Health
- Class Cancer vaccines; Protein vaccines; Viral vaccines
- Mechanism of Action Immunomodulators; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Autoimmune disorders; Cancer; Influenza virus infections; Viral infections
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Autoimmune-disorders in Taiwan (Parenteral)
- 28 Jul 2018 No recent reports of development identified for research development in Cancer in Taiwan (Parenteral)
- 28 Jul 2018 No recent reports of development identified for research development in Influenza-virus-infections in Taiwan (Parenteral)